Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial.

Ricardo Ladeiras-LopesFrancisco SampaioSara LeiteDiogo Santos-FerreiraEduardo VilelaAdelino Leite-MoreiraNuno BettencourtVasco GamaPedro BragaRicardo Fontes-Carvalho

Published in: Endocrine (2021)

Treatment with metformin of non-diabetic MetS patients with diastolic dysfunction, on top of lifestyle counseling, is associated with improved diastolic function.

Keyphrases

left ventricular
metabolic syndrome
blood pressure
ejection fraction
type diabetes
oxidative stress
wound healing
physical activity
heart failure
weight loss
smoking cessation
tyrosine kinase
cardiovascular risk factors
hiv infected